<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-22839" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Herpes Simplex Type 1</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Saleh</surname>
            <given-names>Dahlia</given-names>
          </name>
          <aff>Sampson Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Yarrarapu</surname>
            <given-names>Siva Naga S.</given-names>
          </name>
          <aff>Monmouth Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sharma</surname>
            <given-names>Sandeep</given-names>
          </name>
          <aff>Mery Fitzgerald Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Dahlia Saleh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Siva Naga Yarrarapu declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sandeep Sharma declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>28</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-22839.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Herpes simplex virus type 1 (HSV-1) is a linear dsDNA virus that is a member of the Alphaherpesviridae subfamily. HSV-1 is responsible for establishing primary and recurrent vesicular eruptions, primarily in the orolabial and genital mucosa. HSV-1 infection has a wide variety of presentations, including orolabial herpes, herpetic sycosis (HSV folliculitis), herpes gladiatorum, herpetic whitlow, ocular HSV infection, herpes encephalitis, Kaposi varicelliform eruption (eczema herpeticum), and severe or chronic HSV infection. Antiviral therapy limits the course of HSV infection. This activity describes the evaluation, and treatment herpes simplex virus type 1 and reviews the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of a herpes type 1 infection.</p></list-item><list-item><p>Review the risk factors for herpes type 1 infection.</p></list-item><list-item><p>Explain the presentation of a patient with herpes type 1 infection.</p></list-item><list-item><p>Outline the importance of improving care coordination amongst interprofessional team members to improve outcomes for patients affected by the herpes type 1 virus infection.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22839&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22839">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-22839.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Herpes simplex virus type 1 (HSV-1) is a member of the Alphaherpesviridae subfamily. Its structure is composed of linear dsDNA, an icosahedral capsid that is 100 to 110 nm in diameter, with a spikey envelope. In general, the pathogenesis of HSV-1 infection follows a cycle of primary infection of epithelial cells, latency primarily in neurons, and reactivation. HSV-1 is responsible for establishing primary and recurrent vesicular eruptions, primarily in the orolabial and genital mucosa. HSV-1 infection has a wide variety of presentations, including orolabial herpes, herpetic sycosis (HSV folliculitis), herpes gladiatorum, herpetic whitlow, ocular HSV infection, herpes encephalitis, Kaposi varicelliform eruption (eczema herpeticum), and severe or chronic HSV infection. Antiviral therapy limits the course of HSV infection.<xref ref-type="bibr" rid="article-22839.r1">[1]</xref><xref ref-type="bibr" rid="article-22839.r2">[2]</xref><xref ref-type="bibr" rid="article-22839.r3">[3]</xref></p>
      </sec>
      <sec id="article-22839.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Risk factors for HSV-1 infection differ depending on the type of HSV-1 infection. In the case of orolabial herpes, risk factors include any activity that exposes one to an infected patient&#x02019;s saliva, for example, shared drinkware or cosmetics, or mouth to mouth contact.</p>
        <p>The major risk factor for herpetic sycosis is close shaving with a razor blade in the presence of an acute orolabial infection.</p>
        <p>Risk factors for herpes gladiatorum include participation in high-contact sports such as rugby, wrestling, MMA, and boxing.</p>
        <p>Risk factors for herpetic whitlow include thumb sucking and nail biting in the presence of orolabial HSV-1 infection in the child population, and medical/dental profession in the adult population (although HSV-2 most commonly causes herpetic whitlow in adults).</p>
        <p>A major risk factor for herpes encephalitis is mutations in the toll-like receptor (TLR-3) or <italic toggle="yes">UNC-93B</italic> genes. It has been postulated that these mutations inhibit normal interferon-based responses.</p>
        <p>The major risk factor for eczema herpeticum is skin barrier dysfunction. This can be seen in atopic dermatitis, Darier disease, Hailey-Hailey disease, mycosis fungoides, and all types of ichthyosis. The increased risk is also associated with mutations in the filaggrin gene, which is seen in atopic dermatitis and ichthyosis vulgaris. Pharmaceutical risk factors for eczema herpeticum include the use of topical calcineurin inhibitors such as pimecrolimus and tacrolimus.</p>
        <p>Risk factors for severe or chronic HSV infection include immunocompromised states such as transplant recipients (solid organ or hematopoietic stem cells), HIV infection, or leukemia/lymphoma patients.<xref ref-type="bibr" rid="article-22839.r4">[4]</xref><xref ref-type="bibr" rid="article-22839.r5">[5]</xref></p>
      </sec>
      <sec id="article-22839.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>It has been hypothesized that approximately one-third of the world&#x02019;s population has experienced symptomatic HSV-1 at some point throughout his or her lifetime. HSV-1 first establishes <italic toggle="yes">primary infection </italic>in patients with no existing antibodies to HSV-1 or HSV-2. <italic toggle="yes">Non-primary initial infection</italic> is defined as infection with one HSV subtype in patients who already have antibodies to the other HSV type (i.e., HSV-1 infection in a patient with HSV-2 antibodies, or vice versa). <italic toggle="yes">Reactivation</italic> results in recurrent infection and most commonly presents as asymptomatic viral shedding.</p>
        <p>Approximately 1 in 1000 newborns in the United States experience a neonatal herpes simplex virus infection, resulting from HSV exposure during vaginal delivery. Women with recurrent genital herpes have a low risk of vertically transmitting HSV to their neonate. However, women who acquire a genital HSV infection during pregnancy have a higher risk.</p>
        <p>Epidemiologically, it is important to note that herpes encephalitis is the leading cause of lethal encephalitis in the United States, and ocular HSV infection is a common cause of blindness in the United States.<xref ref-type="bibr" rid="article-22839.r6">[6]</xref><xref ref-type="bibr" rid="article-22839.r7">[7]</xref><xref ref-type="bibr" rid="article-22839.r8">[8]</xref><xref ref-type="bibr" rid="article-22839.r9">[9]</xref><xref ref-type="bibr" rid="article-22839.r10">[10]</xref></p>
      </sec>
      <sec id="article-22839.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>HSV-1 is typically spread through direct contact with contaminated saliva or other infected bodily secretions, as opposed to HSV-2, which is spread primarily by sexual contact. HSV-1 begins to replicate at the site of infection (mucocutaneous) and then proceeds to travel by retrograde flow down an axon to the dorsal root ganglia (DRG). It is in the DRG that latency is established. This latency period allows the virus to remain in a non-infectious state for a variable amount of time before reactivation.&#x000a0; HSV-1 is sly in its ability to evade the immune system via several mechanisms. One such mechanism is inducing an intercellular&#x000a0;accumulation of CD1d molecules in antigen presenting cells. Normally, these CD1d molecules are transported to the cell surface, where the antigen is presented resulting in the stimulation of natural killer T-cells, thus promoting immune response. When CD1d molecules are sequestered intercellularly, the immune response is inhibited. HSV-1 has several other mechanisms by which it down-regulates various immunologic cells and cytokines.<xref ref-type="bibr" rid="article-22839.r11">[11]</xref><xref ref-type="bibr" rid="article-22839.r12">[12]</xref><xref ref-type="bibr" rid="article-22839.r13">[13]</xref><xref ref-type="bibr" rid="article-22839.r14">[14]</xref><xref ref-type="bibr" rid="article-22839.r15">[15]</xref><xref ref-type="bibr" rid="article-22839.r16">[16]</xref></p>
      </sec>
      <sec id="article-22839.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Classic, though not pathognomonic, histologic findings for HSV infection include ballooning degeneration of keratinocytes and multinucleated giant cells. Multinucleated keratinocytes may contain Cowdry A inclusions, which are eosinophilic nuclear inclusions that can also be seen in other herpesviruses such as varicella-zoster virus (VZV) and cytomegalovirus (CMV). There is no pathognomonic histologic finding for HSV-1 infection, and therefore, clinical correlation is crucial during histopathologic evaluation.<xref ref-type="bibr" rid="article-22839.r12">[12]</xref></p>
      </sec>
      <sec id="article-22839.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>It is important to note that HSV-1 infection is frequently asymptomatic. When symptoms do occur, there is a wide range of clinical presentations including orolabial herpes, herpetic sycosis (HSV folliculitis), herpes gladiatorum, herpetic whitlow, ocular HSV infection, herpes encephalitis, Kaposi varicelliform eruption (eczema herpeticum), and severe or chronic HSV-1 infection.</p>
        <p>HSV-1 is the most common culprit of orolabial herpes (a small percent of cases are attributed to HSV-2). It is important to note that orolabial HSV-1 infection is most commonly asymptomatic. When there are symptoms, the most common manifestation is the &#x0201c;cold sore&#x0201d; or fever blister. In children, symptomatic orolabial HSV-1 infections often present as gingivostomatitis that leads to pain, halitosis, and dysphagia. In adults, it can present as pharyngitis and a mononucleosis-like syndrome.<xref ref-type="bibr" rid="article-22839.r17">[17]</xref></p>
        <p>Symptoms of a <italic toggle="yes">primary </italic>orolabial infection occur between three days and one week after the exposure. Patients will often experience a viral prodrome consisting of malaise, anorexia, fevers, tender lymphadenopathy, localized pain, tenderness, burning, or tingling prior to the onset of mucocutaneous lesions. Primary HSV-1 lesions usually occur on the mouth and lips. Patients will then demonstrate painful grouped vesicles on an erythematous base. These vesicles exhibit a characteristic scalloped border. These vesicles may then progress to pustules, erosions, and ulcerations. Within 2 to 6 weeks, the lesions crust over and symptoms resolve.<xref ref-type="bibr" rid="article-22839.r18">[18]</xref></p>
        <p>Symptoms of <italic toggle="yes">recurrent</italic> orolabial infection are typically milder than those of primary infection, with a 24-hour prodrome of tingling, burning, and itch. Recurrent orolabial HSV-1 infections classically affect the vermillion border of the lip (as opposed to the mouth and lips as seen in primary infection).<xref ref-type="bibr" rid="article-22839.r19">[19]</xref></p>
        <p>Initial or recurrent HSV-1 infections may affect the hair follicle, and when this occurs, it is termed herpetic sycosis (HSV folliculitis). This will present on the beard area of a male with a history of close razor blade shaving. Lesions exist on a spectrum ranging from scattered follicular papules with erosion to large lesions involving the entire beard area. Herpetic sycosis is self-limited, with a resolution of eroded papules within 2 to 3 weeks.</p>
        <p>Lesions of herpes gladiatorum will be seen on the lateral neck, side of the face, and forearms within 4 to 11 days after exposure. A high suspicion for this diagnosis is crucial in athletes, as this is commonly misdiagnosed as bacterial folliculitis.</p>
        <p>HSV-1 infection can also occur on the digits or periungual, causing herpetic whitlow. &#x000a0;Herpetic whitlow presents as deep blisters that may secondarily erode. A common misdiagnosis is an acute paronychia or blistering dactylitis.&#x000a0; Herpetic whitlow can also lead to lymphadenopathy of the epitrochlear or axillary lymph nodes in association with lymphatic streaking, mimicking bacterial cellulitis.</p>
        <p>HSV-1 infection of the eye leads to ocular HSV in children and adults. Primary ocular HSV presents with keratoconjunctivitis that can be unilateral or bilateral. There can be associated eyelid tearing, edema, photophobia, chemosis (swelling of the conjunctiva), and preauricular lymphadenopathy. It is common for patients to experience recurrence, and in these cases, it is usually unilateral. Ocular HSV is a common cause of blindness in the United States when it manifests as keratitis or a branching dendritic corneal ulcer (which is pathognomonic for ocular HSV).</p>
        <p>Herpes encephalitis is a severe, typically fatal (mortality is greater than 70% if untreated) infection caused by HSV-1. It primarily affects the temporal lobe of the brain leading to bizarre behavior and focal neurological deficits localized to the temporal lobe. Patients may have a fever and altered mental status as well.</p>
        <p>Kaposi varicelliform eruption, or eczema herpeticum, presents as an extensive spreading of HSV infection in the setting of a compromised skin barrier (e.g., atopic dermatitis, Darier disease, pemphigus foliaceous, pemphigus vulgaris, Hailey-Hailey disease, mycosis fungoides, ichthyosis). Patients will display 2 to 3 mm punched-out erosions with hemorrhagic crusts in widespread distribution. There may be secondary impetigo with <italic toggle="yes">Staphylococcus</italic> or <italic toggle="yes">Streptococcus</italic> species.</p>
        <p>Neonatal herpes virus presents at day 5 to 14 of life and favors the scalp and the trunk. It may present with disseminated cutaneous lesions and involvement of oral and ocular mucosa. Central nervous system (CNS) involvement may occur and manifest as encephalitis with lethargy, poor feeding, bulging fontanelle, irritability, and seizures.&#x000a0;</p>
        <p>In the immunocompromised patient population, HSV infection can result in severe and chronic infection. The most common presentation of severe and chronic HSV infection is quickly enlarging ulcerations or verrucous/pustular lesions. It is not uncommon for patients to have respiratory or gastrointestinal tract involvement and present with dyspnea or dysphagia.<xref ref-type="bibr" rid="article-22839.r20">[20]</xref><xref ref-type="bibr" rid="article-22839.r21">[21]</xref><xref ref-type="bibr" rid="article-22839.r22">[22]</xref><xref ref-type="bibr" rid="article-22839.r23">[23]</xref><xref ref-type="bibr" rid="article-22839.r24">[24]</xref></p>
      </sec>
      <sec id="article-22839.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The gold standard for diagnosing HSV-1 infection is HSV-1 serology (antibody detection via western blot). The most sensitive and specific mechanism is viral polymerase chain reaction (PCR). However, serology remains the gold standard. Viral culture, direct fluorescent antibody&#x000a0; (DFA) assay, and Tzanck smear are alternative methods of diagnosing. It is important to note that the Tzanck smear identifies multinucleated giant cells, so it cannot distinguish between HSV and VZV. The DFA assay, however, can distinguish between the 2 entities.<xref ref-type="bibr" rid="article-22839.r14">[14]</xref></p>
      </sec>
      <sec id="article-22839.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>For the treatment of orolabial herpes, the current recommendation is oral valacyclovir (2 grams twice daily for one day). If the patient has frequent outbreaks, chronic suppression is warranted. For chronic suppression of immunocompetent patients, oral valacyclovir 500 mg daily (for patients with less than ten outbreaks per year) or oral valacyclovir 1 gram by mouth daily (for patients with greater than 10&#x000a0;outbreaks a year) is recommended.</p>
        <p>For the treatment of eczema herpeticum, it is recommended to use 10 to 14 days of either acyclovir (15 mg/kg with a 400 mg maximum) 3 to 5 times daily or Valacyclovir 1 gram by mouth twice a day.</p>
        <p>For immunocompromised patients with severe and chronic HSV, treatment is aimed at chronic suppression. For chronic suppression of immunocompromised patients, oral acyclovir 400 to 800 2 to 3 times daily, or oral valacyclovir 500 mg twice daily is recommended.<xref ref-type="bibr" rid="article-22839.r25">[25]</xref><xref ref-type="bibr" rid="article-22839.r26">[26]</xref><xref ref-type="bibr" rid="article-22839.r27">[27]</xref><xref ref-type="bibr" rid="article-22839.r28">[28]</xref></p>
      </sec>
      <sec id="article-22839.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of orolabial HSV-1 infection includes aphthous stomatitis, Stevens-Johnson syndrome, erythema multiforme (EM) major, and herpangina. These entities can be distinguished from orolabial herpes by history and physical exam findings. The differential diagnosis of herpetic whitlow includes blistering dactylitis and acute or chronic paronychia.</p>
      </sec>
      <sec id="article-22839.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Overall, the vast majority of HSV-1 infections are asymptomatic, and if symptomatic&#x000a0;present with mild recurrent mucocutaneous lesions. The prognosis of HSV-1 infection varies depending on the manifestation and location of the HSV-1 infection. The majority of the time, HSV-1 infection follows a chronic course of latency and reactivation. HSV encephalitis is associated with high mortality; approximately 70% of untreated cases are ultimately fatal. The prognosis of ocular HSV can also be grim if the patient develops globe rupture or corneal scarring, as&#x000a0;these processes can ultimately lead to blindness.<xref ref-type="bibr" rid="article-22839.r29">[29]</xref></p>
      </sec>
      <sec id="article-22839.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Herpes type 1 infections are best managed by an interprofessional team that includes the primary provider, pediatrician, nurse practitioner, infectious disease specialist and the internist. The key to treatment is starting the antiviral within 24 hours of symptoms. It is important to understand that most infections spontaneously subside on their own and delayed treatment has no impact on duration or severity of symptoms. During the infection, the patient should be educated on washing hands and avoiding close contact with others.</p>
      </sec>
      <sec id="article-22839.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22839&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22839">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/herpes-simplex-type-1/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=22839">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/22839/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=22839">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-22839.s14">
        <fig id="article-22839.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Herpes Simplex <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dermnetnz.org/images">DermNet New Zealand</ext-link></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="herpes__simplex" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-22839.s15">
        <fig id="article-22839.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Herpes Simplex Keratitis Clinical Features. Various clinical findings of herpetic keratitis are demonstrated. In image A (top), herpetic keratitis with neovascularization of the cornea is noted. In image B (middle), HSV type 1 lesions are seen on the patient's lips and chin. Image C (bottom) demonstrates findings of stage 1 neurotrophic keratitis, including fluorescein epithelial staining with Gaule spots, which are scattered areas of dried epithelium. Contributed by BCK Patel, MD, FRCS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Herpes__Simplex-1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-22839.s16">
        <fig id="article-22839.image.f3" position="float" orientation="portrait">
          <caption>
            <p>This image depicts a close view of a patient&#x02019;s penile shaft, highlighting the presence of a crop of erythematous vesiculopapular lesions, which were determined to have been caused by a herpes genitalis outbreak. Genital herpes is a sexually transmitted disease caused by the herpes simplex viruses type-1 (HSV-1), and type-2 (HSV-2), however, most genital herpes is caused by HSV-2. Symptoms typically include one or more blisters on or around the genitals or rectum. Contributed from the CDC/ Susan Lindsley (Public Domain)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="6480_lores" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-22839.s17">
        <fig id="article-22839.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Herpes Simplex on genitals Contributed by Dr. Shyam Verma, MBBS, DVD, FRCP, FAAD, Vadodara, India</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="herpes__simplex__SV1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-22839.s18">
        <fig id="article-22839.image.f5" position="float" orientation="portrait">
          <caption>
            <p>Herpes Simplex mouth Contributed by Dr. Shyam Verma, MBBS, DVD, FRCP, FAAD, Vadodara, India</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="herpes__simplex__SV1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-22839.s19">
        <title>References</title>
        <ref id="article-22839.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rechenchoski</surname>
                <given-names>DZ</given-names>
              </name>
              <name>
                <surname>Faccin-Galhardi</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Linhares</surname>
                <given-names>REC</given-names>
              </name>
              <name>
                <surname>Nozawa</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Herpesvirus: an underestimated virus.</article-title>
            <source>Folia Microbiol (Praha)</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>62</volume>
            <issue>2</issue>
            <fpage>151</fpage>
            <page-range>151-156</page-range>
            <pub-id pub-id-type="pmid">27858281</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soriano</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Romero</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Rebound in Sexually Transmitted Infections Following the Success of Antiretrovirals for HIV/AIDS.</article-title>
            <source>AIDS Rev</source>
            <year>2018</year>
            <volume>20</volume>
            <issue>4</issue>
            <fpage>187</fpage>
            <page-range>187-204</page-range>
            <pub-id pub-id-type="pmid">30548023</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mostafa</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Konen</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Haenchen</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Hilliard</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Macdonald</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Morrison</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Davido</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Herpes Simplex Virus 1 Mutant with Point Mutations in <italic>UL39</italic> Is Impaired for Acute Viral Replication in Mice, Establishment of Latency, and Explant-Induced Reactivation.</article-title>
            <source>J Virol</source>
            <year>2018</year>
            <month>Apr</month>
            <day>01</day>
            <volume>92</volume>
            <issue>7</issue>
            <pub-id pub-id-type="pmid">29321311</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pfaff</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Groth</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sauerbrei</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zell</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Genotyping of herpes simplex virus type 1 by whole-genome sequencing.</article-title>
            <source>J Gen Virol</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>97</volume>
            <issue>10</issue>
            <fpage>2732</fpage>
            <page-range>2732-2741</page-range>
            <pub-id pub-id-type="pmid">27558891</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Oeffelen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Biekram</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Poeran</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hukkelhoven</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Galjaard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>van der Meijden</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Op de Coul</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Update on Neonatal Herpes Simplex Epidemiology in the Netherlands: A Health Problem of Increasing Concern?</article-title>
            <source>Pediatr Infect Dis J</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>37</volume>
            <issue>8</issue>
            <fpage>806</fpage>
            <page-range>806-813</page-range>
            <pub-id pub-id-type="pmid">29356762</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chaabane</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Harfouche</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chemaitelly</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Schwarzer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Abu-Raddad</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Herpes simplex virus type 1 epidemiology in the Middle East and North Africa: systematic review, meta-analyses, and meta-regressions.</article-title>
            <source>Sci Rep</source>
            <year>2019</year>
            <month>Feb</month>
            <day>04</day>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>1136</fpage>
            <pub-id pub-id-type="pmid">30718696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fedoreyev</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Krylova</surname>
                <given-names>NV</given-names>
              </name>
              <name>
                <surname>Mishchenko</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Vasileva</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Pislyagin</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Iunikhina</surname>
                <given-names>OV</given-names>
              </name>
              <name>
                <surname>Lavrov</surname>
                <given-names>VF</given-names>
              </name>
              <name>
                <surname>Svitich</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>Ebralidze</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Leonova</surname>
                <given-names>GN</given-names>
              </name>
            </person-group>
            <article-title>Antiviral and Antioxidant Properties of Echinochrome A.</article-title>
            <source>Mar Drugs</source>
            <year>2018</year>
            <month>Dec</month>
            <day>15</day>
            <volume>16</volume>
            <issue>12</issue>
            <pub-id pub-id-type="pmid">30558297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jiang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Leib</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Preventing neonatal herpes infections through maternal immunization.</article-title>
            <source>Future Virol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>12</volume>
            <issue>12</issue>
            <fpage>709</fpage>
            <page-range>709-711</page-range>
            <pub-id pub-id-type="pmid">29339967</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marchi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Trombetta</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Gasparini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Temperton</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Montomoli</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014.</article-title>
            <source>J Prev Med Hyg</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>58</volume>
            <issue>1</issue>
            <fpage>E27</fpage>
            <page-range>E27-E33</page-range>
            <pub-id pub-id-type="pmid">28515628</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Finger-Jardim</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Avila</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>da Hora</surname>
                <given-names>VP</given-names>
              </name>
              <name>
                <surname>Gon&#x000e7;alves</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>de Martinez</surname>
                <given-names>AMB</given-names>
              </name>
              <name>
                <surname>Soares</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of herpes simplex virus types 1 and 2 at maternal and fetal sides of the placenta in asymptomatic pregnant women.</article-title>
            <source>Am J Reprod Immunol</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>78</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">28440579</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosenberg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Galen</surname>
                <given-names>BT</given-names>
              </name>
            </person-group>
            <article-title>Recurrent Meningitis.</article-title>
            <source>Curr Pain Headache Rep</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>21</volume>
            <issue>7</issue>
            <fpage>33</fpage>
            <pub-id pub-id-type="pmid">28551737</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cruz</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Freedman</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Kulik</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Okada</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Fleming</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Mistry</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Thomson</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Schnadower</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Arms</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Mahajan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Garro</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Pruitt</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Balamuth</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Uspal</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Aronson</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Lyons</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Curtis</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Ishimine</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Bradin</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Grether-Jones</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Louie</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Nigrovic</surname>
                <given-names>LE</given-names>
              </name>
              <collab>HSV Study Group of the Pediatric Emergency Medicine Collaborative Research Committee</collab>
            </person-group>
            <article-title>Herpes Simplex Virus Infection in Infants Undergoing Meningitis Evaluation.</article-title>
            <source>Pediatrics</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>141</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">29298827</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Immune response of T cells during herpes simplex virus type 1 (HSV-1) infection.</article-title>
            <source>J Zhejiang Univ Sci B</source>
            <string-date>2017 Apr.</string-date>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>277</fpage>
            <page-range>277-288</page-range>
            <pub-id pub-id-type="pmid">28378566</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giraldo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wilcox</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Longnecker</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The Type I Interferon Response and Age-Dependent Susceptibility to Herpes Simplex Virus Infection.</article-title>
            <source>DNA Cell Biol</source>
            <year>2017</year>
            <month>May</month>
            <volume>36</volume>
            <issue>5</issue>
            <fpage>329</fpage>
            <page-range>329-334</page-range>
            <pub-id pub-id-type="pmid">28278385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rajasagi</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Rouse</surname>
                <given-names>BT</given-names>
              </name>
            </person-group>
            <article-title>Application of our understanding of pathogenesis of herpetic stromal keratitis for novel therapy.</article-title>
            <source>Microbes Infect</source>
            <year>2018</year>
            <season>Oct-Nov</season>
            <volume>20</volume>
            <issue>9-10</issue>
            <fpage>526</fpage>
            <page-range>526-530</page-range>
            <pub-id pub-id-type="pmid">29329934</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Richers</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Streib</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>DYM</given-names>
              </name>
            </person-group>
            <article-title>Ankyrin repeat domain 1 regulates innate immune responses against herpes simplex virus 1: A&#x000a0;potential role in eczema herpeticum.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>141</volume>
            <issue>6</issue>
            <fpage>2085</fpage>
            <page-range>2085-2093.e1</page-range>
            <pub-id pub-id-type="pmid">29371118</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Darji</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Frisch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Adjei Boakye</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Siegfried</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Characterization of children with recurrent eczema herpeticum and response to treatment with interferon-gamma.</article-title>
            <source>Pediatr Dermatol</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>34</volume>
            <issue>6</issue>
            <fpage>686</fpage>
            <page-range>686-689</page-range>
            <pub-id pub-id-type="pmid">29144049</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wei</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Coghlin</surname>
                <given-names>DT</given-names>
              </name>
            </person-group>
            <article-title>Beyond Folliculitis: Recognizing Herpes Gladiatorum in Adolescent Athletes.</article-title>
            <source>J Pediatr</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>190</volume>
            <fpage>283</fpage>
            <pub-id pub-id-type="pmid">28728810</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Williams</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wells</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sylvester</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sunenshine</surname>
                <given-names>R</given-names>
              </name>
              <collab>Centers for Disease Control and Prevention (CDC)</collab>
            </person-group>
            <article-title>Notes from the field: outbreak of skin lesions among high school wrestlers--Arizona, 2014.</article-title>
            <source>MMWR Morb Mortal Wkly Rep</source>
            <year>2015</year>
            <month>May</month>
            <day>29</day>
            <volume>64</volume>
            <issue>20</issue>
            <fpage>559</fpage>
            <page-range>559-60</page-range>
            <pub-id pub-id-type="pmid">26020140</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kolawole</surname>
                <given-names>OM</given-names>
              </name>
              <name>
                <surname>Amuda</surname>
                <given-names>OO</given-names>
              </name>
              <name>
                <surname>Nzurumike</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Suleiman</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Ikhevha Ogah</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Seroprevalence and Co-Infection of Human Immunodeficiency Virus (HIV) and Herpes Simplex Virus (HSV) Among Pregnant Women in Lokoja, North-Central Nigeria.</article-title>
            <source>Iran Red Crescent Med J</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>18</volume>
            <issue>10</issue>
            <fpage>e25284</fpage>
            <pub-id pub-id-type="pmid">28180012</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El Hayderi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>R&#x000fc;bben</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nikkels</surname>
                <given-names>AF</given-names>
              </name>
            </person-group>
            <article-title>The alpha-herpesviridae in dermatology : Herpes simplex virus types&#x000a0;I and II.</article-title>
            <source>Hautarzt</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>68</volume>
            <issue>Suppl 1</issue>
            <fpage>1</fpage>
            <page-range>1-5</page-range>
            <pub-id pub-id-type="pmid">28197698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shenoy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mostow</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cain</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Eczema herpeticum in a wrestler.</article-title>
            <source>Clin J Sport Med</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>e18</fpage>
            <page-range>e18-9</page-range>
            <pub-id pub-id-type="pmid">24714395</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Breitwieser</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jun</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Asnaghi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Salzberg</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Eberhart</surname>
                <given-names>CG</given-names>
              </name>
            </person-group>
            <article-title>Identifying Corneal Infections in Formalin-Fixed Specimens Using Next Generation Sequencing.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2018</year>
            <month>Jan</month>
            <day>01</day>
            <volume>59</volume>
            <issue>1</issue>
            <fpage>280</fpage>
            <page-range>280-288</page-range>
            <pub-id pub-id-type="pmid">29340642</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El Hayderi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>R&#x000fc;bben</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nikkels</surname>
                <given-names>AF</given-names>
              </name>
            </person-group>
            <article-title>[The alpha-herpesviridae in dermatology : Herpes simplex virus types&#x000a0;I and II. German version].</article-title>
            <source>Hautarzt</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>68</volume>
            <issue>3</issue>
            <fpage>181</fpage>
            <page-range>181-186</page-range>
            <pub-id pub-id-type="pmid">28197699</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sanders</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Pediatric herpes simplex virus infections: an evidence-based approach to treatment.</article-title>
            <source>Pediatr Emerg Med Pract</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-19; quiz 19</page-range>
            <pub-id pub-id-type="pmid">24649621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalogeropoulos</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Geka</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Malamos</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kanari</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kalogeropoulos</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>New Therapeutic Perceptions in a Patient with Complicated Herpes Simplex Virus 1 Keratitis: A Case Report and Review of the Literature.</article-title>
            <source>Am J Case Rep</source>
            <year>2017</year>
            <month>Dec</month>
            <day>27</day>
            <volume>18</volume>
            <fpage>1382</fpage>
            <page-range>1382-1389</page-range>
            <pub-id pub-id-type="pmid">29279602</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anderson</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>McGuire</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Reed</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ortiz</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Prophylactic Valacyclovir to Prevent Outbreaks of Primary Herpes Gladiatorum at a 28-Day Wrestling Camp: A 10-Year Review.</article-title>
            <source>Clin J Sport Med</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>272</fpage>
            <page-range>272-8</page-range>
            <pub-id pub-id-type="pmid">26540599</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mir-Bonaf&#x000e9;</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Rom&#x000e1;n-Curto</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Santos-Briz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Palacios-&#x000c1;lvarez</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Santos-Dur&#x000e1;n</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-L&#x000f3;pez</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Eczema herpeticum with herpetic folliculitis after bone marrow transplant under prophylactic acyclovir: are patients with underlying dermatologic disorders at higher risk?</article-title>
            <source>Transpl Infect Dis</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>E75</fpage>
            <page-range>E75-80</page-range>
            <pub-id pub-id-type="pmid">23387866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22839.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gottlieb</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Giersing</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Hickling</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Deal</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kaslow</surname>
                <given-names>DC</given-names>
              </name>
              <collab>HSV Vaccine Expert Consultation Group</collab>
            </person-group>
            <article-title>Meeting report: Initial World Health Organization consultation on herpes simplex virus (HSV) vaccine preferred product characteristics, March 2017.</article-title>
            <source>Vaccine</source>
            <year>2019</year>
            <month>Nov</month>
            <day>28</day>
            <volume>37</volume>
            <issue>50</issue>
            <fpage>7408</fpage>
            <page-range>7408-7418</page-range>
            <pub-id pub-id-type="pmid">29224963</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
